On the public citation graph

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

0 signed · 872 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1006/jmbi.1994.1334openalex-snapshot

Satisfying Hydrogen Bonding Potential in Proteins

inferredcites →https://doi.org/10.1016/j.coi.2010.02.012openalex-snapshot

Rational antibody-based HIV-1 vaccine design: current approaches and future directions

inferredcites →https://doi.org/10.1016/j.immuni.2004.12.011openalex-snapshot

Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41

inferredcites →https://doi.org/10.1016/j.immuni.2008.10.010openalex-snapshot

Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control

inferredcites →https://doi.org/10.1016/j.jim.2007.09.017openalex-snapshot

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

inferredcites →https://doi.org/10.1016/j.jmb.2006.10.088openalex-snapshot

Structural Basis of Enhanced Binding of Extended and Helically Constrained Peptide Epitopes of the Broadly Neutralizing HIV-1 Antibody 4E10

inferredcites →https://doi.org/10.1016/j.jmb.2007.05.022openalex-snapshot

Inference of Macromolecular Assemblies from Crystalline State

inferredcites →https://doi.org/10.1016/j.jmb.2008.09.024openalex-snapshot

Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site

inferredcites →https://doi.org/10.1016/s0042-6822(03)00294-0openalex-snapshot

Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition

inferredcites →https://doi.org/10.1016/s0076-6879(97)76066-xopenalex-snapshot

[20] Processing of X-ray diffraction data collected in oscillation mode

inferredcites →https://doi.org/10.1038/nature10373openalex-snapshot

Broad neutralization coverage of HIV by multiple highly potent antibodies

inferredcites →https://doi.org/10.1038/nbt.2197openalex-snapshot

B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study

inferredcites →https://doi.org/10.1038/nm.1949openalex-snapshot

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

inferredcites →https://doi.org/10.1073/pnas.0800255105openalex-snapshot

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

inferredcites →https://doi.org/10.1073/pnas.0908713106openalex-snapshot

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

inferredcites →https://doi.org/10.1073/pnas.1004728107openalex-snapshot

Elicitation of structure-specific antibodies by epitope scaffolds

inferredcites →https://doi.org/10.1073/pnas.181342398openalex-snapshot

Electrostatics of nanosystems: Application to microtubules and the ribosome

inferredcites →https://doi.org/10.1084/jem.20101907openalex-snapshot

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

inferredcites →https://doi.org/10.1086/317641openalex-snapshot

Human Immunodeficiency Virus Type 1 Quasi Species That Rebound after Discontinuation of Highly Active Antiretroviral Therapy Are Similar to the Viral Quasi Species Present before Initiation of Therapy

inferredcites →https://doi.org/10.1093/nar/gkm216openalex-snapshot

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

inferredcites →https://doi.org/10.1097/coh.0b013e32832e06feopenalex-snapshot

Specificities of broadly neutralizing anti-HIV-1 sera

inferredcites →https://doi.org/10.1107/s0021889807021206openalex-snapshot

Phaser crystallographic software

inferredcites →https://doi.org/10.1107/s0907444902016657openalex-snapshot

PHENIX : building new software for automated crystallographic structure determination

inferredcites →https://doi.org/10.1107/s0907444904019158openalex-snapshot

Coot : model-building tools for molecular graphics

inferredcites →https://doi.org/10.1107/s0907444910045749openalex-snapshot

Overview of the CCP 4 suite and current developments

inferredcites →https://doi.org/10.1126/science.1111781openalex-snapshot

Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

inferredcites →https://doi.org/10.1126/science.1178746openalex-snapshot

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

inferredcites →https://doi.org/10.1126/science.1187659openalex-snapshot

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

inferredcites →https://doi.org/10.1126/science.1207227openalex-snapshot

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

inferredcites →https://doi.org/10.1126/science.1207532openalex-snapshot

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

inferredcites →https://doi.org/10.1126/science.7973652openalex-snapshot

Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody

inferredcites →https://doi.org/10.1128/jvi.00110-09openalex-snapshot

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

inferredcites →https://doi.org/10.1128/jvi.00239-07openalex-snapshot

Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection

inferredcites →https://doi.org/10.1128/jvi.00685-09openalex-snapshot

A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies

inferredcites →https://doi.org/10.1128/jvi.00756-11openalex-snapshot

Direct Antibody Access to the HIV-1 Membrane-Proximal External Region Positively Correlates with Neutralization Sensitivity

inferredcites →https://doi.org/10.1128/jvi.00758-09openalex-snapshot

Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors

inferredcites →https://doi.org/10.1128/jvi.01359-09openalex-snapshot

Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region

inferredcites →https://doi.org/10.1128/jvi.01482-09openalex-snapshot

Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables

inferredcites →https://doi.org/10.1128/jvi.02036-08openalex-snapshot

Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection

inferredcites →https://doi.org/10.1128/jvi.02658-10openalex-snapshot

Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

inferredcites →https://doi.org/10.1128/jvi.05045-11openalex-snapshot

Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

inferredcites →https://doi.org/10.1128/jvi.05363-11openalex-snapshot

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

inferredcites →https://doi.org/10.1128/jvi.05489-11openalex-snapshot

Binding of Anti-Membrane-Proximal gp41 Monoclonal Antibodies to CD4-Liganded and -Unliganded Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Virions

inferredcites →https://doi.org/10.1128/jvi.07139-11openalex-snapshot

Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site

inferredcites →https://doi.org/10.1128/jvi.07163-11openalex-snapshot

Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design

inferredcites →https://doi.org/10.1128/jvi.67.11.6642-6647.1993openalex-snapshot

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

inferredcites →https://doi.org/10.1128/jvi.75.22.10892-10905.2001openalex-snapshot

Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

inferredcites →https://doi.org/10.1128/jvi.76.10.4810-4821.2002openalex-snapshot

Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells

inferredcites →https://doi.org/10.1128/jvi.78.19.10724-10737.2004openalex-snapshot

Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope

inferredcites →https://doi.org/10.1128/jvi.79.16.10108-10125.2005openalex-snapshot

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

inferredcites →https://doi.org/10.1128/jvi.79.2.1252-1261.2005openalex-snapshot

Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1

inferredcites →https://doi.org/10.1128/jvi.80.4.1680-1687.2006openalex-snapshot

Structure-Function Analysis of the Epitope for 4E10, a Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody

inferredcites →https://doi.org/10.1371/journal.pone.0023532openalex-snapshot

Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting

inferredcites →https://doi.org/10.1371/journal.ppat.1001028openalex-snapshot

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3416843openalex-extracted

Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody

inferred← citeshttps://doi.org/10.2139/ssrn.3986221openalex-extracted

The Gp120 Alters its Conformation to Enhance Evasiveness and Infectivity

inferred← citeshttps://doi.org/10.1002/1873-3468.14814openalex-snapshot

A two‐step mechanism for the binding of the HIV ‐1 MPER epitope by the 10 E 8 antibody onto biosensor‐supported lipid bilayers

inferred← citeshttps://doi.org/10.1002/9780470015902.a0021550.pub3openalex-snapshot

HIV Vaccine Approaches

inferred← citeshttps://doi.org/10.1002/advs.202003468openalex-snapshot

Cholesterol in the Viral Membrane is a Molecular Switch Governing HIV‐1 Env Clustering

inferred← citeshttps://doi.org/10.1002/ange.201508421openalex-snapshot

Trimerization of the HIV Transmembrane Domain in Lipid Bilayers Modulates Broadly Neutralizing Antibody Binding

inferred← citeshttps://doi.org/10.1002/ange.201903093openalex-snapshot

Unidirectional Presentation of Membrane Proteins in Nanoparticle‐Supported Liposomes

inferred← citeshttps://doi.org/10.1002/ange.202008804openalex-snapshot

Concentration‐Dependent Structural Transition of the HIV‐1 gp41 MPER Peptide into α‐Helical Trimers

inferred← citeshttps://doi.org/10.1002/anie.201508421openalex-snapshot

Trimerization of the HIV Transmembrane Domain in Lipid Bilayers Modulates Broadly Neutralizing Antibody Binding

inferred← citeshttps://doi.org/10.1002/anie.201903093openalex-snapshot

Unidirectional Presentation of Membrane Proteins in Nanoparticle‐Supported Liposomes

inferred← citeshttps://doi.org/10.1002/anie.202008804openalex-snapshot

Concentration‐Dependent Structural Transition of the HIV‐1 gp41 MPER Peptide into α‐Helical Trimers

inferred← citeshttps://doi.org/10.1002/cmdc.201500498openalex-snapshot

Broadly Neutralizing Antibody‐Guided Carbohydrate‐Based HIV Vaccine Design: Challenges and Opportunities

inferred← citeshttps://doi.org/10.1002/eji.201242974openalex-snapshot

Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library

inferred← citeshttps://doi.org/10.1002/iid3.52openalex-snapshot

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques

inferred← citeshttps://doi.org/10.1002/pro.2540openalex-snapshot

Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV ‐1 gp41

inferred← citeshttps://doi.org/10.1002/pro.2750openalex-snapshot

Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus‐1 gp41 and equine infectious anemia virus gp45

inferred← citeshttps://doi.org/10.1002/prot.24641openalex-snapshot

Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5

inferred← citeshttps://doi.org/10.1002/psc.2482openalex-snapshot

Max Bergmann lecture Protein epitope mimetics in the age of structural vaccinology

inferred← citeshttps://doi.org/10.1002/smtd.202000451openalex-snapshot

Deep Mining of Human Antibody Repertoires: Concepts, Methodologies, and Applications

inferred← citeshttps://doi.org/10.1007/7355_2014_45openalex-snapshot

Targeting Cellular Cofactors in HIV Therapy

inferred← citeshttps://doi.org/10.1007/82_2020_221openalex-snapshot

Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design

inferred← citeshttps://doi.org/10.1007/978-1-4614-8872-9_5openalex-snapshot

Molecular Recognition of HIV Glycans by Antibodies

inferred← citeshttps://doi.org/10.1007/978-1-4939-1655-9_26openalex-snapshot

Antibody-based Protection Against HIV Infection

inferred← citeshttps://doi.org/10.1007/978-1-4939-2432-5_8openalex-snapshot

Vector-Mediated Antibody Gene Transfer for Infectious Diseases

inferred← citeshttps://doi.org/10.1007/978-3-031-10992-8_11openalex-snapshot

Antibodies Against Biofilms: Mechanisms and Applications

inferred← citeshttps://doi.org/10.1007/978-3-031-77911-4_4openalex-snapshot

Monoclonal Antibodies Against Human Immunodeficiency Virus (HIV): Current Opinion

inferred← citeshttps://doi.org/10.1007/978-3-319-54220-1_2openalex-snapshot

Computer-Based Technologies for Virtual Screening and Analysis of Chemical Compounds Promising for Anti-HIV-1 Drug Design

inferred← citeshttps://doi.org/10.1007/978-3-319-72077-7_12openalex-snapshot

Using High-Throughput Sequencing to Characterize the Development of the Antibody Repertoire During Infections: A Case Study of HIV-1

inferred← citeshttps://doi.org/10.1007/978-981-13-0484-2_3openalex-snapshot

HIV Broadly Neutralizing Antibodies: VRC01 and Beyond

inferred← citeshttps://doi.org/10.1007/978-981-13-0484-2_4openalex-snapshot

Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine

inferred← citeshttps://doi.org/10.1007/s00705-015-2710-xopenalex-snapshot

Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting

inferred← citeshttps://doi.org/10.1007/s00705-016-2942-4openalex-snapshot

VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice

inferred← citeshttps://doi.org/10.1007/s00705-018-4011-7openalex-snapshot

Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1007/s10529-016-2267-0openalex-snapshot

Eliciting 10E8-like antibodies by the membrane proximal external region peptide of HIV-1 in guinea pigs

inferred← citeshttps://doi.org/10.1007/s10822-014-9805-4openalex-snapshot

Insight into the modified Ibalizumab–human CD4 receptor interactions: using a computational binding free energy approach

inferred← citeshttps://doi.org/10.1007/s11427-013-4591-0openalex-snapshot

10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime

inferred← citeshttps://doi.org/10.1007/s11517-023-02950-8openalex-snapshot

Inactivation of cell-free HIV-1 by designing potent peptides based on mutations in the CD4 binding site

inferred← citeshttps://doi.org/10.1007/s11684-019-0721-9openalex-snapshot

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

inferred← citeshttps://doi.org/10.1007/s12026-013-8430-yopenalex-snapshot

Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV)

inferred← citeshttps://doi.org/10.1007/s12250-021-00361-3openalex-snapshot

Exploration of a Sequential Gp140-Gp145 Immunization Regimen with Heterologous Envs to Induce a Protective Cross-Reactive HIV Neutralizing Antibody Response In Non-human Primates

inferred← citeshttps://doi.org/10.1007/s13238-012-2111-9openalex-snapshot

Closing the door to human immunodeficiency virus

inferred← citeshttps://doi.org/10.1007/s13238-018-0534-7openalex-snapshot

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects

inferred← citeshttps://doi.org/10.1007/s13337-020-00595-xopenalex-snapshot

Analysis of sequence diversity and selection pressure in HIV-1 clade C gp41 from India

inferred← citeshttps://doi.org/10.1016/b978-0-12-397933-9.00024-2openalex-snapshot

The Cellular and Molecular Biology of HIV-1 Broadly Neutralizing Antibodies

inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.02532-0openalex-snapshot

Antigenic Variation☆

inferred← citeshttps://doi.org/10.1016/b978-0-12-802174-3.00015-1openalex-snapshot

Antiviral Vaccines: Challenges and Advances

inferred← citeshttps://doi.org/10.1016/b978-0-12-816328-3.00007-6openalex-snapshot

Functional and Protective Role of Neutralizing Antibodies (NAbs) Against Viral Infections

inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00029-8openalex-snapshot

Human Immunodeficiency Virus Vaccines

inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00031-1openalex-snapshot

Human Immunodeficiency Virus Vaccines

inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00123-5openalex-snapshot

The Immunology of Human Immunodeficiency Virus Infection

inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00132-6openalex-snapshot

Vaccines for Human Immunodeficiency Virus Type 1 Infection

inferred← citeshttps://doi.org/10.1016/bs.ai.2015.09.004openalex-snapshot

Evolution of the Humoral Response during HCV Infection

inferred← citeshttps://doi.org/10.1016/bs.ai.2017.01.004openalex-snapshot

Humanized Immunoglobulin Mice

inferred← citeshttps://doi.org/10.1016/bs.apcsb.2015.03.002openalex-snapshot

The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER

inferred← citeshttps://doi.org/10.1016/j.addr.2016.01.013openalex-snapshot

Engineering broadly neutralizing antibodies for HIV prevention and therapy

inferred← citeshttps://doi.org/10.1016/j.antiviral.2013.09.009openalex-snapshot

Construction and characterisation of replicating foamy viral vectors expressing HIV-1 epitopes recognised by broadly neutralising antibodies

inferred← citeshttps://doi.org/10.1016/j.antiviral.2013.09.027openalex-snapshot

Antibody-based concepts for multipurpose prevention technologies

inferred← citeshttps://doi.org/10.1016/j.antiviral.2015.02.006openalex-snapshot

Reconstitution and characterization of antibody repertoires of HIV-1-infected “elite neutralizers”

inferred← citeshttps://doi.org/10.1016/j.antiviral.2016.06.013openalex-snapshot

Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120

inferred← citeshttps://doi.org/10.1016/j.antiviral.2021.105085openalex-snapshot

Differential expression of HIV envelope epitopes on the surface of HIV-Infected macrophages and CD4+ T cells

inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105834openalex-snapshot

Neutralizing antibodies to block viral entry and for identification of entry inhibitors

inferred← citeshttps://doi.org/10.1016/j.antiviral.2026.106487openalex-snapshot

Bridging the vaccine gap: Scientific and technological advances for diseases lacking effective vaccines

inferred← citeshttps://doi.org/10.1016/j.bbamem.2018.02.019openalex-snapshot

Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds

inferred← citeshttps://doi.org/10.1016/j.bbamem.2023.184235openalex-snapshot

Liposome-based peptide vaccines to elicit immune responses against the membrane active domains of the HIV-1 Env glycoprotein

inferred← citeshttps://doi.org/10.1016/j.bbamem.2025.184413openalex-snapshot

A simulation analysis of the effect of a cholesterol-dependent fusogenic peptide from HIV gp41 on membrane phospholipid dynamics

inferred← citeshttps://doi.org/10.1016/j.bbapap.2014.05.010openalex-snapshot

Immunogen design for HIV-1 and influenza

inferred← citeshttps://doi.org/10.1016/j.bbrc.2018.11.063openalex-snapshot

The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses

inferred← citeshttps://doi.org/10.1016/j.biotechadv.2018.07.003openalex-snapshot

Phage display: an important tool in the discovery of peptides with anti-HIV activity

inferred← citeshttps://doi.org/10.1016/j.biotechadv.2023.108143openalex-snapshot

Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis

inferred← citeshttps://doi.org/10.1016/j.bpj.2023.01.026openalex-snapshot

Quantitative characterization of membrane-protein reversible association using FCS

inferred← citeshttps://doi.org/10.1016/j.cell.2013.03.018openalex-snapshot

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

inferred← citeshttps://doi.org/10.1016/j.cell.2014.01.052openalex-snapshot

Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy

inferred← citeshttps://doi.org/10.1016/j.cell.2015.01.016openalex-snapshot

Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1

inferred← citeshttps://doi.org/10.1016/j.cell.2015.05.007openalex-snapshot

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

inferred← citeshttps://doi.org/10.1016/j.cell.2016.04.050openalex-snapshot

Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency

inferred← citeshttps://doi.org/10.1016/j.cell.2016.05.024openalex-snapshot

Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity

inferred← citeshttps://doi.org/10.1016/j.cell.2021.02.013openalex-snapshot

Antivirals with common targets against highly pathogenic viruses

inferred← citeshttps://doi.org/10.1016/j.cell.2021.04.042openalex-snapshot

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

inferred← citeshttps://doi.org/10.1016/j.cell.2024.04.033openalex-snapshot

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

inferred← citeshttps://doi.org/10.1016/j.celrep.2018.01.023openalex-snapshot

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody

inferred← citeshttps://doi.org/10.1016/j.celrep.2020.107583openalex-snapshot

HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies

inferred← citeshttps://doi.org/10.1016/j.celrep.2020.108037openalex-snapshot

Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane Environments

inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109084openalex-snapshot

Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies

inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109167openalex-snapshot

Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells

inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109611openalex-snapshot

Tandem bispecific antibody prevents pathogenic SHIVSF162P3CN infection and disease progression

inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110611openalex-snapshot

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

inferred← citeshttps://doi.org/10.1016/j.celrep.2022.111624openalex-snapshot

HIV-1 Vpu restricts Fc-mediated effector functions in vivo

inferred← citeshttps://doi.org/10.1016/j.celrep.2022.111983openalex-snapshot

Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity

inferred← citeshttps://doi.org/10.1016/j.celrep.2023.112755openalex-snapshot

HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide

inferred← citeshttps://doi.org/10.1016/j.celrep.2023.112942openalex-snapshot

Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes

inferred← citeshttps://doi.org/10.1016/j.celrep.2024.115010openalex-snapshot

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.celrep.2024.115163openalex-snapshot

Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class

inferred← citeshttps://doi.org/10.1016/j.celrep.2025.116818openalex-snapshot

Cryo-EM structures of antibodies elicited by germline-targeting HIV MPER epitope scaffolds

inferred← citeshttps://doi.org/10.1016/j.celrep.2025.116905openalex-snapshot

Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaques

inferred← citeshttps://doi.org/10.1016/j.celrep.2026.117180openalex-snapshot

Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine development

inferred← citeshttps://doi.org/10.1016/j.celrep.2026.117582openalex-snapshot

Public antibody clonotypes and deep learning identify SARS-CoV-2 and HIV broadly neutralizing antibodies in immune repertoires

inferred← citeshttps://doi.org/10.1016/j.chembiol.2017.09.005openalex-snapshot

Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses

inferred← citeshttps://doi.org/10.1016/j.chembiol.2022.03.009openalex-snapshot

Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.chom.2012.09.008openalex-snapshot

A Blueprint for HIV Vaccine Discovery

inferred← citeshttps://doi.org/10.1016/j.chom.2016.02.002openalex-snapshot

HIV-Host Interactions: Implications for Vaccine Design

inferred← citeshttps://doi.org/10.1016/j.chom.2017.07.010openalex-snapshot

Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1

inferred← citeshttps://doi.org/10.1016/j.chom.2017.07.013openalex-snapshot

Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design

inferred← citeshttps://doi.org/10.1016/j.chom.2017.08.011openalex-snapshot

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin

inferred← citeshttps://doi.org/10.1016/j.chom.2018.12.001openalex-snapshot

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

inferred← citeshttps://doi.org/10.1016/j.chom.2019.09.016openalex-snapshot

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

inferred← citeshttps://doi.org/10.1016/j.chom.2020.03.024openalex-snapshot

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA

inferred← citeshttps://doi.org/10.1016/j.chom.2023.06.006openalex-snapshot

Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller

inferred← citeshttps://doi.org/10.1016/j.clim.2023.109809openalex-snapshot

Broadly neutralizing antibodies targeting HIV: Progress and challenges

inferred← citeshttps://doi.org/10.1016/j.clim.2025.110594openalex-snapshot

B cell receptor repertoires identified by next-generation sequencing showed signatures associated with incomplete immune reconstitution in people living with HIV

inferred← citeshttps://doi.org/10.1016/j.clp.2021.03.004openalex-snapshot

HIV in Neonates and Infants

inferred← citeshttps://doi.org/10.1016/j.coi.2013.07.003openalex-snapshot

Host–pathogen interaction in HIV infection

inferred← citeshttps://doi.org/10.1016/j.coi.2016.05.013openalex-snapshot

Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.coviro.2013.05.010openalex-snapshot

Advances in structure-based vaccine design

inferred← citeshttps://doi.org/10.1016/j.coviro.2015.02.002openalex-snapshot

Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

inferred← citeshttps://doi.org/10.1016/j.coviro.2015.03.013openalex-snapshot

Computational tools for epitope vaccine design and evaluation

inferred← citeshttps://doi.org/10.1016/j.coviro.2015.04.002openalex-snapshot

Strategies to guide the antibody affinity maturation process

inferred← citeshttps://doi.org/10.1016/j.coviro.2019.04.004openalex-snapshot

Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir

inferred← citeshttps://doi.org/10.1016/j.crmicr.2024.100263openalex-snapshot

Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation

inferred← citeshttps://doi.org/10.1016/j.ebiom.2016.04.040openalex-snapshot

Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants

inferred← citeshttps://doi.org/10.1016/j.ebiom.2016.08.045openalex-snapshot

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity

inferred← citeshttps://doi.org/10.1016/j.ebiom.2026.106297openalex-snapshot

HIV-1 virome profiling using HIV-PULSE to guide therapeutic and curative interventions

inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.119122openalex-snapshot

Aromatic π-stacking stabilizes an α-helical SARS-CoV-2 MPER peptide that mimics the post-fusion spike and enables potent antiviral activity

inferred← citeshttps://doi.org/10.1016/j.febslet.2013.10.014openalex-snapshot

Protein engineering strategies for the development of viral vaccines and immunotherapeutics

inferred← citeshttps://doi.org/10.1016/j.idc.2014.08.004openalex-snapshot

Human Immunodeficiency Virus Vaccines

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.143157openalex-snapshot

Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopes

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.145715openalex-snapshot

A novel FITC.Chimeric antigen receptor-T cell targeting HIV-1-infected cells with FITC-conjugated antibodies for enhanced cytotoxicity

inferred← citeshttps://doi.org/10.1016/j.imlet.2013.01.011openalex-snapshot

Possible explanations for the broadly neutralizing activity of HIV-1 gp41 specific monoclonal antibodies by recognition pattern based amino acid sequence analyses

inferred← citeshttps://doi.org/10.1016/j.imlet.2015.10.003openalex-snapshot

Elicitation of HIV-1 neutralizing antibodies by presentation of 4E10 and 10E8 epitopes on Norovirus P particles

inferred← citeshttps://doi.org/10.1016/j.imlet.2016.04.005openalex-snapshot

Identifying possible sites for antibody neutralization escape: Implications for unique functional properties of the C-terminal tail of Human Immunodeficiency Virus Type 1 gp41

inferred← citeshttps://doi.org/10.1016/j.imlet.2019.07.004openalex-snapshot

HIV-1 Membrane-Proximal External Region Fused to Diphtheria Toxin Domain-A Elicits 4E10-Like Antibodies in Mice

inferred← citeshttps://doi.org/10.1016/j.immuni.2012.08.012openalex-snapshot

Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies

inferred← citeshttps://doi.org/10.1016/j.immuni.2013.08.031openalex-snapshot

Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses

inferred← citeshttps://doi.org/10.1016/j.immuni.2014.04.008openalex-snapshot

Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers

inferred← citeshttps://doi.org/10.1016/j.immuni.2014.04.009openalex-snapshot

Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers

inferred← citeshttps://doi.org/10.1016/j.immuni.2015.08.012openalex-snapshot

Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point

inferred← citeshttps://doi.org/10.1016/j.immuni.2015.12.001openalex-snapshot

Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10

inferred← citeshttps://doi.org/10.1016/j.immuni.2016.06.026openalex-snapshot

A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans

inferred← citeshttps://doi.org/10.1016/j.immuni.2018.04.029openalex-snapshot

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure

inferred← citeshttps://doi.org/10.1016/j.immuni.2018.12.017openalex-snapshot

An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes

inferred← citeshttps://doi.org/10.1016/j.immuni.2019.02.005openalex-snapshot

Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression

inferred← citeshttps://doi.org/10.1016/j.immuni.2019.02.008openalex-snapshot

Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

inferred← citeshttps://doi.org/10.1016/j.isci.2021.102987openalex-snapshot

Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile

inferred← citeshttps://doi.org/10.1016/j.isci.2022.105473openalex-snapshot

Adjuvants influence the maturation of VRC01-like antibodies during immunization

inferred← citeshttps://doi.org/10.1016/j.isci.2023.107579openalex-snapshot

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody

inferred← citeshttps://doi.org/10.1016/j.isci.2024.110141openalex-snapshot

Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs

inferred← citeshttps://doi.org/10.1016/j.it.2014.02.010openalex-snapshot

Emerging concepts on T follicular helper cell dynamics in HIV infection

inferred← citeshttps://doi.org/10.1016/j.it.2016.01.007openalex-snapshot

HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies

inferred← citeshttps://doi.org/10.1016/j.jbc.2026.111350openalex-snapshot

Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer

inferred← citeshttps://doi.org/10.1016/j.jconrel.2017.09.030openalex-snapshot

Targeted microbicides for preventing sexual HIV transmission

inferred← citeshttps://doi.org/10.1016/j.jim.2013.09.003openalex-snapshot

Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160ΔcBaL

inferred← citeshttps://doi.org/10.1016/j.jim.2020.112901openalex-snapshot

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.jmb.2013.09.030openalex-snapshot

Disruption of Helix-Capping Residues 671 and 674 Reveals a Role in HIV-1 Entry for a Specialized Hinge Segment of the Membrane Proximal External Region of gp41

inferred← citeshttps://doi.org/10.1016/j.jmb.2013.12.012openalex-snapshot

Understanding the conundrums of viral assembly

inferred← citeshttps://doi.org/10.1016/j.jmb.2017.03.008openalex-snapshot

Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane

inferred← citeshttps://doi.org/10.1016/j.jmb.2021.166909openalex-snapshot

N-terminal Transmembrane-Helix Epitope Tag for X-ray Crystallography and Electron Microscopy of Small Membrane Proteins

inferred← citeshttps://doi.org/10.1016/j.jmgm.2015.08.003openalex-snapshot

Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01

inferred← citeshttps://doi.org/10.1016/j.jviromet.2015.01.006openalex-snapshot

Single genome amplification and standard bulk PCR yield HIV-1 envelope products with similar genotypic and phenotypic characteristics

inferred← citeshttps://doi.org/10.1016/j.micinf.2013.10.001openalex-snapshot

F(ab′)2 fragment of a gp41 NHR-trimer-induced IgM monoclonal antibody neutralizes HIV-1 infection and blocks viral fusion by targeting the conserved gp41 pocket

inferred← citeshttps://doi.org/10.1016/j.micinf.2015.05.003openalex-snapshot

P20A inhibits HIV-1 fusion through its electrostatic interaction with the distal region of the gp41 fusion core

inferred← citeshttps://doi.org/10.1016/j.micpath.2019.103824openalex-snapshot

Cloning, expression and nanodiscs assemble of recombinant HIV-1 gp41

inferred← citeshttps://doi.org/10.1016/j.molimm.2016.10.011openalex-snapshot

Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo

inferred← citeshttps://doi.org/10.1016/j.molmed.2019.01.007openalex-snapshot

Broadly Neutralizing Antibodies against HIV: Back to Blood

inferred← citeshttps://doi.org/10.1016/j.omtm.2023.02.004openalex-snapshot

A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin

inferred← citeshttps://doi.org/10.1016/j.omtn.2018.09.003openalex-snapshot

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

inferred← citeshttps://doi.org/10.1016/j.sbi.2013.03.007openalex-snapshot

HIV-1 envelope glycoprotein structure

inferred← citeshttps://doi.org/10.1016/j.sbi.2024.102897openalex-snapshot

Influence of membrane on the antigen presentation of the HIV-1 envelope membrane proximal external region (MPER)

inferred← citeshttps://doi.org/10.1016/j.smim.2021.101470openalex-snapshot

HIV vaccinology: 2021 update

inferred← citeshttps://doi.org/10.1016/j.smim.2021.101475openalex-snapshot

Broadly neutralizing antibodies for HIV-1 prevention and therapy

inferred← citeshttps://doi.org/10.1016/j.str.2018.10.007openalex-snapshot

Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition

inferred← citeshttps://doi.org/10.1016/j.tim.2013.06.004openalex-snapshot

Catching HIV ‘in the act’ with 3D electron microscopy

inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.02.068openalex-snapshot

Report of the Cent Gardes HIV Vaccine Conference the B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5–7 November 2012

inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.05.071openalex-snapshot

Immunogenicity and safety of the vaccinia virus LC16m8Δ vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol

inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.09.003openalex-snapshot

Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies

inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.10.020openalex-snapshot

Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.12.045openalex-snapshot

Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides

inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.06.072openalex-snapshot

Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines

inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.03.039openalex-snapshot

Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region

inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.09.077openalex-snapshot

DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens

inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.03.008openalex-snapshot

Sendai virus particles carrying target virus glycoproteins for antibody induction

inferred← citeshttps://doi.org/10.1016/j.virol.2012.10.004openalex-snapshot

Broadly neutralizing antibodies against HIV-1: Templates for a vaccine

inferred← citeshttps://doi.org/10.1016/j.virol.2014.03.015openalex-snapshot

Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques

inferred← citeshttps://doi.org/10.1016/j.virol.2014.06.006openalex-snapshot

Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence

inferred← citeshttps://doi.org/10.1016/j.virol.2014.06.018openalex-snapshot

Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner

inferred← citeshttps://doi.org/10.1016/j.virol.2014.10.036openalex-snapshot

Sequence variation of koala retrovirus transmembrane protein p15E among koalas from different geographic regions

inferred← citeshttps://doi.org/10.1016/j.virol.2015.09.010openalex-snapshot

Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region

inferred← citeshttps://doi.org/10.1016/j.virol.2016.01.002openalex-snapshot

Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure

inferred← citeshttps://doi.org/10.1016/j.virol.2016.09.011openalex-snapshot

Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India

inferred← citeshttps://doi.org/10.1016/j.virol.2016.10.026openalex-snapshot

Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.virol.2017.02.015openalex-snapshot

Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region

inferred← citeshttps://doi.org/10.1016/j.virol.2017.02.024openalex-snapshot

Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction

inferred← citeshttps://doi.org/10.1016/j.virol.2017.04.008openalex-snapshot

A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles

inferred← citeshttps://doi.org/10.1016/j.virol.2017.05.015openalex-snapshot

Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.virol.2018.04.002openalex-snapshot

Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category

inferred← citeshttps://doi.org/10.1016/j.virol.2024.110158openalex-snapshot

Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1

inferred← citeshttps://doi.org/10.1016/j.virusres.2017.10.011openalex-snapshot

Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies

inferred← citeshttps://doi.org/10.1016/j.virusres.2019.197763openalex-snapshot

Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8

inferred← citeshttps://doi.org/10.1016/j.virusres.2020.198001openalex-snapshot

CD4 binding loop responsible for the neutralization of human monoclonal neutralizing antibody Y498

inferred← citeshttps://doi.org/10.1016/j.virusres.2021.198470openalex-snapshot

Identification of a CD4-binding site-directed antibody with ADCC activity from a chronic HIV-1B′-infected Chinese donor

inferred← citeshttps://doi.org/10.1016/j.virusres.2024.199377openalex-snapshot

Amino acid substitution of the membrane-proximal external region alter neutralization sensitivity in a chronic HIV-1 clade B infected patient

inferred← citeshttps://doi.org/10.1016/j.ymeth.2017.01.003openalex-snapshot

Antibodies: From novel repertoires to defining and refining the structure of biologically important targets

showing the first 200 of 818 · page through all 818

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.